» Articles » PMID: 35522713

Structural Insights into Ras Regulation by SIN1

Overview
Specialty Science
Date 2022 May 6
PMID 35522713
Authors
Affiliations
Soon will be listed here.
Abstract

Over the years it has been established that SIN1, a key component of mTORC2, could interact with Ras family small GTPases through its Ras-binding domain (RBD). The physical association of Ras and SIN1/mTORC2 could potentially affect both mTORC2 and Ras-ERK pathways. To decipher the precise molecular mechanism of this interaction, we determined the high-resolution structures of HRas/KRas-SIN1 RBD complexes, showing the detailed interaction interface. Mutation of critical interface residues abolished Ras-SIN1 interaction and in SIN1 knockout cells we demonstrated that Ras-SIN1 association promotes SGK1 activity but inhibits insulin-induced ERK activation. With structural comparison and competition fluorescence resonance energy transfer (FRET) assays we showed that HRas-SIN1 RBD association is much weaker than HRas-Raf1 RBD but is slightly stronger than HRas-PI3K RBD interaction, providing a possible explanation for the different outcome of insulin or EGF stimulation. We also found that SIN1 isoform lacking the PH domain binds stronger to Ras than other longer isoforms and the PH domain appears to have an inhibitory effect on Ras-SIN1 binding. In addition, we uncovered a Ras dimerization interface that could be critical for Ras oligomerization. Our results advance our understanding of Ras-SIN1 association and crosstalk between growth factor-stimulated pathways.

Citing Articles

Targeting the mTOR-Autophagy Axis: Unveiling Therapeutic Potentials in Osteoporosis.

Chen R, Yang C, Yang F, Yang A, Xiao H, Peng B Biomolecules. 2024; 14(11).

PMID: 39595628 PMC: 11591800. DOI: 10.3390/biom14111452.


Motif-guided identification of KRAS-interacting proteins.

Wu S, Gao X, Wu D, Liu L, Yao H, Meng X BMC Biol. 2024; 22(1):264.

PMID: 39563372 PMC: 11575137. DOI: 10.1186/s12915-024-02067-w.


Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.

Wang Y, Vandewalle N, de Veirman K, Vanderkerken K, Menu E, de Bruyne E Cell Commun Signal. 2024; 22(1):320.

PMID: 38862983 PMC: 11165851. DOI: 10.1186/s12964-024-01699-3.


Negative Regulation of Autophagy during Macrophage Infection by BCG via Protein Kinase C Activation.

Maldonado-Bravo R, Villasenor T, Pedraza-Escalona M, Perez-Martinez L, Hernandez-Pando R, Pedraza-Alva G Int J Mol Sci. 2024; 25(6).

PMID: 38542119 PMC: 10970242. DOI: 10.3390/ijms25063145.


Conformational States of the GDP- and GTP-Bound HRAS Affected by A59E and K117R: An Exploration from Gaussian Accelerated Molecular Dynamics.

Yu Z, Wang Z, Cui X, Cao Z, Zhang W, Sun K Molecules. 2024; 29(3).

PMID: 38338389 PMC: 10856033. DOI: 10.3390/molecules29030645.


References
1.
Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung S . SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127(1):125-37. DOI: 10.1016/j.cell.2006.08.033. View

2.
Buhrman G, Holzapfel G, Fetics S, Mattos C . Allosteric modulation of Ras positions Q61 for a direct role in catalysis. Proc Natl Acad Sci U S A. 2010; 107(11):4931-6. PMC: 2841912. DOI: 10.1073/pnas.0912226107. View

3.
Park E, Rawson S, Li K, Kim B, Ficarro S, Gonzalez-Del Pino G . Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes. Nature. 2019; 575(7783):545-550. PMC: 7014971. DOI: 10.1038/s41586-019-1660-y. View

4.
Krygowska A, Castellano E . PI3K: A Crucial Piece in the RAS Signaling Puzzle. Cold Spring Harb Perspect Med. 2017; 8(6). PMC: 5983164. DOI: 10.1101/cshperspect.a031450. View

5.
Solman M, Ligabue A, Blazevits O, Jaiswal A, Zhou Y, Liang H . Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation. Elife. 2015; 4:e08905. PMC: 4563131. DOI: 10.7554/eLife.08905. View